1. Home
  2. STRO vs OM Comparison

STRO vs OM Comparison

Compare STRO & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • OM
  • Stock Information
  • Founded
  • STRO 2003
  • OM 2003
  • Country
  • STRO United States
  • OM United States
  • Employees
  • STRO N/A
  • OM N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • STRO Health Care
  • OM Health Care
  • Exchange
  • STRO Nasdaq
  • OM Nasdaq
  • Market Cap
  • STRO 50.0M
  • OM 50.5M
  • IPO Year
  • STRO 2018
  • OM 2020
  • Fundamental
  • Price
  • STRO $0.52
  • OM $11.01
  • Analyst Decision
  • STRO Buy
  • OM Buy
  • Analyst Count
  • STRO 7
  • OM 2
  • Target Price
  • STRO $6.83
  • OM $45.00
  • AVG Volume (30 Days)
  • STRO 1.4M
  • OM 141.8K
  • Earning Date
  • STRO 05-12-2025
  • OM 05-07-2025
  • Dividend Yield
  • STRO N/A
  • OM N/A
  • EPS Growth
  • STRO N/A
  • OM N/A
  • EPS
  • STRO N/A
  • OM N/A
  • Revenue
  • STRO $62,043,000.00
  • OM $113,689,000.00
  • Revenue This Year
  • STRO N/A
  • OM $8.98
  • Revenue Next Year
  • STRO $1.29
  • OM $12.74
  • P/E Ratio
  • STRO N/A
  • OM N/A
  • Revenue Growth
  • STRO N/A
  • OM N/A
  • 52 Week Low
  • STRO $0.54
  • OM $5.85
  • 52 Week High
  • STRO $5.17
  • OM $78.30
  • Technical
  • Relative Strength Index (RSI)
  • STRO 29.82
  • OM 52.11
  • Support Level
  • STRO $0.54
  • OM $10.30
  • Resistance Level
  • STRO $0.78
  • OM $11.65
  • Average True Range (ATR)
  • STRO 0.09
  • OM 1.20
  • MACD
  • STRO 0.02
  • OM 0.08
  • Stochastic Oscillator
  • STRO 0.00
  • OM 65.42

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Share on Social Networks: